Chen Z et al (2020) Recent progress in treatment of hepatocellular carcinoma. Am J Cancer Res 10:2993–3036
CAS PubMed PubMed Central Google Scholar
Couri T, Pillai A (2019) Goals and targets for personalized therapy for HCC. Hepatol Int 13:125–137
Gunarathne LS et al (2020) Cirrhotic portal hypertension: from pathophysiology to novel therapeutics. World J Gastroenterol 26:6111–6140
Article CAS PubMed PubMed Central Google Scholar
Iwakiri Y, Trebicka J (2021) Portal hypertension in cirrhosis: pathophysiological mechanisms and therapy. JHEP Rep: Innov Hepatol 3:100316
Reig M et al (2022) BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update. J Hepatol 76:681–693
Choi GH et al (2011) Predictive factors for long-term survival in patients with clinically significant portal hypertension following resection of hepatocellular carcinoma. Liver Int 31:485–493
Article CAS PubMed Google Scholar
Casellas-Robert M et al (2020) Laparoscopic Liver resection for hepatocellular carcinoma in Child-Pugh a patients with and without portal hypertension: a multicentre study. World J Surg 44:3915–3922
D’Silva M et al (2022) Limited liver resections in the posterosuperior segments: international multicentre propensity score-matched and coarsened exact-matched analysis comparing the laparoscopic and robotic approaches. Br J Surg 109(11):1140–1149
Aghayan DL et al (2019) Laparoscopic versus open liver resection in the posterosuperior segments: a sub-group analysis from the OSLO-COMET randomized controlled trial. HPB (Oxford) 21:1485–1490
El-Gendi A et al (2018) Laparoscopic versus open hepatic resection for solitary hepatocellular carcinoma less than 5 cm in cirrhotic patients: a randomized controlled study. J Laparoendosc Adv Surg Tech A 28:302–310
Fretland ÅA et al (2018) Laparoscopic versus open resection for colorectal liver metastases: the OSLO-COMET randomized controlled trial. Ann Surg 267:199–207
Robles-Campos R et al (2019) Open versus minimally invasive liver surgery for colorectal liver metastases (LapOpHuva): a prospective randomized controlled trial. Surg Endosc 33:3926–3936
Xia F et al (2023) Clinically Significant Portal Hypertension (CSPH) on early-stage HCC following hepatectomy: what’s the impact? Eur J Surg Oncol 49:771–779
EASL Clinical Practice Guidelines (2018) Management of hepatocellular carcinoma. J Hepatol 69:182–236
Vogel A et al (2018) Hepatocellular carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 29:iv238–iv255
Article CAS PubMed Google Scholar
Pang YY (2002) The Brisbane 2000 terminology of liver anatomy and resections. HPB 4:99–100
Rahbari NN et al (2011) Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery 149:713–724
Slankamenac K et al (2013) The comprehensive complication index: a novel continuous scale to measure surgical morbidity. Ann Surg 258:1–7
Barron JO et al (2022) Validation of the IWATE criteria as a laparoscopic liver resection difficulty score in a single North American cohort. Surg Endosc 36:3601–3609
Labadie KP et al (2022) IWATE criteria are associated with perioperative outcomes in robotic hepatectomy: a retrospective review of 225 resections. Surg Endosc 36:889–895
Ishizawa T et al (2012) Laparoscopic segmentectomy of the liver: from segment I to VIII. Ann Surg 256:959–964
Azoulay D et al (2021) Liver resection for hepatocellular carcinoma in patients with clinically significant portal hypertension. JHEP Rep: Innov Hepatol 3:100190
Choi SB et al (2014) Influence of clinically significant portal hypertension on surgical outcomes and survival following hepatectomy for hepatocellular carcinoma: a systematic review and meta-analysis. J Hepatobiliary Pancreat Sci 21:639–647
Zheng J et al (2021) Safety and feasibility of laparoscopic liver resection for hepatocellular carcinoma with clinically significant portal hypertension: a propensity score-matched study. Surg Endosc 35:3267–3278
Giannini EG et al (2013) Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients. Liver Int 33:1594–1600
Article CAS PubMed Google Scholar
Hobeika C et al (2020) Influence of surgical approach and quality of resection on the probability of cure for early-stage HCC occurring in cirrhosis. JHEP Rep: Innov Hepatol 2:100153
Levi Sandri GB et al (2018) Laparoscopic liver resection for large HCC: short- and long-term outcomes in relation to tumor size. Surg Endosc 32:4772–4779
Reddy SK et al (2011) Laparoscopic liver resection. World J Surg 35:1478–1486
Harada N et al (2016) Laparoscopic liver resection is a feasible treatment for patients with hepatocellular carcinoma and portal hypertension. Anticancer Res 36:3489–3497
Søreide JA, Deshpande R (2021) Post hepatectomy liver failure (PHLF)—recent advances in prevention and clinical management. Eur J Surg Oncol: J Eur Soc Surg Oncol British Assoc Surg Oncol 47:216–224
Sposito C et al (2021) Preoperative predictors of liver decompensation after mini-invasive liver resection. Surg Endosc 35:718–727
Wang YY et al (2021) Development and Validation of a nomogram to preoperatively estimate post-hepatectomy liver dysfunction risk and long-term survival in patients with hepatocellular carcinoma. Ann Surg 274:e1209–e1217
Yu Q et al (2022) An imaging-based artificial intelligence model for non-invasive grading of hepatic venous pressure gradient in cirrhotic portal hypertension. Cell Rep Med 3:100563
Article PubMed PubMed Central Google Scholar
Liu Y et al (2020) Deep convolutional neural network-aided detection of portal hypertension in patients with cirrhosis. Clin Gastroenterol Hepatol 18:2998-3007.e5
留言 (0)